| 10th Jul 2020 7:53 am |
PRN |
Atox Bio plans NDA submission for Q3 2020 |
| 8th Jul 2020 1:27 pm |
PRN |
VelosBio completes $137 million Series B financing |
| 1st Jul 2020 7:00 am |
PRN |
Director/PDMR Shareholding, Issue of Ordinary Shares |
| 1st Jul 2020 7:00 am |
PRN |
Director/PDMR Shareholding, Issue of Ordinary Shares |
| 12th Jun 2020 2:24 pm |
PRN |
Aura presents updated AU-011 clinical data at ARVO 2020 |
| 12th Jun 2020 1:34 pm |
PRN |
Imara presents positive interim Phase 2a data at EHA |
| 12th Jun 2020 9:13 am |
PRN |
Autolus AUTO1 and AUTO3 data at EHA |
| 8th Jun 2020 7:08 am |
PRN |
Arix announces strategic and operational update |
| 4th Jun 2020 5:42 pm |
PRN |
Results of Annual General Meeting |
| 1st Jun 2020 2:57 pm |
PRN |
Iterum announces topline Phase 3 data in complicated UTI |
| 29th May 2020 1:38 pm |
PRN |
Harpoon presents interim Phase 1 data for HPN424 |
| 29th May 2020 1:06 pm |
PRN |
Autolus presents additional AUTO3 data in DLBCL |
| 27th May 2020 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 27th May 2020 4:35 pm |
RNS |
Price Monitoring Extension |
| 20th May 2020 7:00 am |
PRN |
Amplyx closes $53 million Series C extension |
| 19th May 2020 9:35 am |
EQS |
Hardman & Co Research: Arix Bioscience (ARIX): 1Q'20 portfolio update |
| 12th May 2020 7:00 am |
PRN |
Notice of Annual General Meeting |
| 28th Apr 2020 9:23 am |
PRN |
Pharmaxis announces new data in myelofibrosis |
| 27th Apr 2020 1:12 pm |
PRN |
Harpoon doses first patient in multiple myeloma trial |
| 23rd Apr 2020 7:30 am |
EQS |
Hardman & Co Research: Arix Bioscience (ARIX): Resetting the stage |
| 17th Apr 2020 2:59 pm |
PRN |
Director/PDMR Shareholding |
| 16th Apr 2020 1:08 pm |
PRN |
Autolus announces FDA acceptance of IND application |
| 6th Apr 2020 7:00 am |
PRN |
Changes to Board of Directors and executive leadership |
| 19th Mar 2020 10:31 am |
EQS |
Hardman & Co Research: Arix Bioscience (ARIX): Fiscal 2019 - moving with the times |
| 16th Mar 2020 7:00 am |
PRN |
Director/PDMR Shareholding |
| 12th Mar 2020 7:11 am |
PRN |
Imara prices Nasdaq IPO |
| 10th Mar 2020 7:00 am |
PRN |
Annual Results for the year ended 31 December 2019 |
| 9th Mar 2020 12:00 pm |
PRN |
Dr Roberto Iacone appointed as EiR |
| 3rd Mar 2020 12:18 pm |
PRN |
Update on Imara proposed IPO in the United States |
| 3rd Mar 2020 7:30 am |
EQS |
Hardman & Co Research: Q&A with Q&A with Dr Dorothea Hill on Arix Bioscience (ARIX) |
| 27th Feb 2020 12:00 pm |
PRN |
Notice of Results |
| 24th Feb 2020 1:26 pm |
PRN |
Aura announces updated Phase 1b/2 clinical data |
| 19th Feb 2020 7:30 am |
EQS |
Hardman & Co Research: Arix Bioscience (ARIX) - Initiation of coverage: With high risk can come high reward |
| 17th Feb 2020 7:00 am |
PRN |
Imara files for proposed IPO in the United States |
| 30th Jan 2020 12:08 pm |
PRN |
Autolus presents encouraging additional AUTO3 data |
| 27th Jan 2020 7:00 am |
PRN |
Arix co-founds Quench Bio with Series A financing |
| 23rd Jan 2020 7:00 am |
PRN |
Autolus announces pricing of public offering |
| 17th Jan 2020 1:15 pm |
PRN |
Iterum announces $52 million private placement |
| 18th Dec 2019 10:00 am |
PRN |
Pharmaxis business update |
| 17th Dec 2019 10:57 am |
PRN |
Board changes |
